Cardiac Ablation Market size to surpass $6.5 Bn by 2026

Cardiac Ablation Market size is anticipated to exceed USD 6.5 billion by 2026; according to a new research report by Global Market Insights, Inc.

Growing burden of cardiovascular disorders worldwide and increasing focus of market competitors on new product development for the treatment of various chronic and infectious diseases will drive cardiac ablation market growth. Moreover, shift of people towards non-invasive surgeries will escalate the adoption of cardiac ablation procedures over the forecast period.


Request Sample Buy NowInquiry Before Buying


Focus of medical device companies on new product development will offer lucrative market growth opportunity

Increasing investment by companies in R&D activities, for development of novel products is one of the key factors driving cardiac ablation devices industry growth. Growing prevalence of cardiovascular diseases across the globe will thus impel the market demand for novel products in the market. Moreover, increasing involvement of government in creating awareness among people about management of cardiovascular diseases will foster adoption of cardiac ablation.

However, post-procedure complications of cardiac ablation procedures and stringent government regulations for approval of ablation devices may impede the industry growth.

North America Cardiac Ablation Market

Get more details on this report - Request Free Sample PDF

Growing adoption of cryoablators for cardiac ablation will favor market expansion

Cryoablation devices market is expected to exceed USD 170 million revenue size by 2026. Growing demand for minimally invasive procedures, cost-effectivity, and availability of customized probes for cryoablation devices will positively impact market growth. Moreover, increase in usage of cryoablation procedures by physicians will increase its demand over the forthcoming years.

Browse key industry insights spread across 151 pages with 252 market data tables & 12 figures & charts from the report, “Cardiac Ablation Market Size By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), By Application (Cardiac Rhythm Management {Atrial Fibrillation & Flutter, Tachycardia}, Open Surgery), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Mexico, Brazil, Argentina, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026” in detail along with the table of contents:

Rising popularity of Maze procedure will increase the use of ablators in open surgery

Cardiac ablation market revenue from ppen surgery segment is anticipated to witness over 12.5% CAGR across the forecast timeframe. Surgical cardiac ablation technology is mainly used to treat atrial fibrillation while undergoing surgery for other CVD. The procedure restores heart’s normal rhythm. Cardiac ablation through open surgery is done through catheters, making the procedure less invasive and risky. Thus, aforementioned factors will offer several opportunities for market expansion.

High-quality and specialized cardiac treatment offered by cardiac centers will offer lucrative market growth

Cardiac centers segment held revenue share in 2019 and is poised to exceed USD 1 billion market size by 2026. High market growth is attributed to expanding specialty centers, increasing spending on cardiovascular diseases and better outcomes. Growing geriatric population vulnerable to various cardiovascular disorders and growing preference for specialized centers will further spur the market size.

Asia Pacific is poised to progress rapidly due to increasing R&D activities and improving healthcare infrastructure

Asia Pacific cardiac ablation market share was more than 22% revenue in 2019 and will robust growth over the analysis timeframe. Regional growth is attributed to increasing awareness and adoption rate of cardiac ablation procedures, rising prevalence of cardiovascular disorders and increasing availability of skilled workforce. Moreover, strong foothold of key industry players focusing on new product development will further accelerate the market expansion in the forthcoming years.

Emphasis of market players on new development products will pave way for industry growth

Some of the notable players operating in the cardiac ablation market share include Abbott Laboratories (St. Jude Medical), AtriCure Inc., Biosense Webster (Johnson & Johnson), Boston Scientific Corporation, Medtronic plc among others. These business leaders primarily focus on strategic alliances including acquisitions & mergers and novel product launches to broaden their product portfolio and capitalize on market opportunities. For instance, in February 2019, AtriCure, Inc. announced the U.S. launch of its product cryoICE cryoSPHERE probe. This launch enabled the company to penetrate the U.S. market.

Explore More on Related Topics:

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X